Keytruda Improves Pleural Mesothelioma Survival in Phase 3 Clinical Trial
By: Devin Golden
June 12, 2023
The immunotherapy drug Keytruda combined with chemotherapy improved survival for people with pleural mesothelioma compared to standard of care chemotherapy. Keytruda, which is the...
Read Post